Abacus Medicine Group

Better Access Better Healthcare

We improve global healthcare through better access to medicine.

Abacus Medicine is firmly established among the market leaders in the European parallel distribution industry. 

Abacus Medicine Pharma Services provides end-to-end commercialisation services to advance access to rare disease medicines in Europe.

Originalis is a parallel distributor of medicine operating in Germany and Ireland.

Pluripharm is a leading wholesaler in the Netherlands and offers a full line of medicines, medical devices and services to a range of customers.

We are innovative, dedicated
and we care.

The Abacus Medicine Group is built on a strong purpose. When we compete in the market, we help lower the prices on life-critical medicines so that they become more widely available. 

The Abacus Medicine Group is a business. We operate commercially, and our activities provide jobs, careers and livelihoods for hundreds of people in dozens of countries. 

But we are more than that. When we compete in the market, we help life-critical medicines become more widely available. This gives us a purpose beyond ourselves and is something we can be proud of.

Flemming Wagner

CEO & majority shareholder


Global locations

+ 0


+ 0

Packs sold in 2023

A career in the Abacus Medicine Group

Join an ambitious and diverse company.
We are always looking for new and dedicated colleagues.

Latest news

Abacus Medicine Group: Record full-year result

The Abacus Medicine Group exceeded the guidance ranges for both revenue and profitability in 2023. A combination of high demand in core sales markets and solid commercial execution drove organic revenue growth of 18% to EUR 1,210 million and EBITDA growth of 82% to EUR 47.5 million.

Read More »

Choose language